Disease Landscape and Forecast Insights

Each year in the United States, thousands of patients with end-stage renal disease undergo a kidney transplant. To prevent rejection and maintain the new kidney’s functionality, patients must…

Clarivate Epidemiology’s coverage of graft versus host disease (GVHD) comprises epidemiological estimates of key patient populations in the emerging pharmaceutical markets (Brazil, China, India,…

Clarivate Epidemiology’s coverage of graft versus host disease (GVHD) comprises epidemiological estimates of key patient populations in the major mature pharmaceutical markets (the United States,…

Each year in the United States, thousands of patients with end-stage renal disease undergo a kidney transplant. To prevent rejection and maintain the new kidney’s functionality, transplant…

Graft versus host disease (GVHD) is a potentially life-threatening complication of allogenic hematopoietic stem cell transplantation (HSCT). Steroids have been the first-line therapy for the…

Each year in the United States, thousands of patients with end-stage renal disease undergo a kidney transplant. To prevent rejection and maintain the new kidney’s functionality, transplant…

MARKET OUTLOOK Each year in the United States, thousands of patients with end-stage renal disease undergo a kidney transplant. To prevent rejection and maintain the new kidney’s functionality…

Each year in the United States, thousands of patients suffering from end-stage renal disease undergo a kidney transplant. To prevent rejection and maintain the new kidney’s functionality, these…

This folder covers DRG’s Company & Drugs (C&D) data for Transplants which include market forecast (US, ROW and Global) and analysis on drug profie, drug group and therapy area.

Each year in the United States, thousands of patients suffering from end-stage renal failure undergo a kidney transplant. To prevent rejection and maintain the new kidney’s functionality, these…

Market Outlook The most important clinical distinction in the first-line treatment of multiple myeloma is determining whether the patient is eligible to undergo autologous stem-cell…

Each year in the United States, more than 17,000 patients suffering from renal failure undergo a kidney transplant. To prevent rejection and maintain the new kidney’s functionality, these…